J. Dumbleton

The Helicobacter Eradication Aspirin Trial (HEAT): A Large Simple Randomised Controlled Trial Using Novel Methodology in Primary Care

D. Kendrick, C. Hawkey, A. Avery, 2015, EBioMedicine.

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

T. Cameron Waller, J. McMurray, P. Jhund, 2020, The Lancet.

Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT)

D. Kendrick, C. Hawkey, A. Avery, 2022, Trials.

Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial

J. Haughney, D. Mant, A. Ford, 2022, The Lancet.

Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatment

R. Terkeltaub, C. Coupland, M. Doherty, 2022, Rheumatology advances in practice.

Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial

J. Waller, B. Delaney, A. Hackshaw, 2023, BMC Gastroenterology.

Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial

A. Doney, C. Hawkey, A. Avery, 2022, The Lancet.